| Jihad Elias Azar, MD | |
|
1111 Franklin St, Ste 300, Johnstown, PA 15905-4330 | |
| (814) 534-9230 | |
| (814) 534-9465 |
| Full Name | Jihad Elias Azar |
|---|---|
| Gender | Male |
| Speciality | Obstetrics/gynecology |
| Experience | 17 Years |
| Location | 1111 Franklin St, Johnstown, Pennsylvania |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1932337086 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207V00000X | Obstetrics & Gynecology | 25MA09319800 (New Jersey) | Primary |
| 207V00000X | Obstetrics & Gynecology | MD447393 (Pennsylvania) | Secondary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Conemaugh Memorial Medical Center | Johnstown, PA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Dlp Conemaugh Physician Practices Llc | 7315166949 | 253 |
News Archive
Three generic drugmakers are being accused in a whistleblower lawsuit of scheming to overcharge the government by tens of millions of dollars for medicines.
Scientists at Benaroya Research Institute at Virginia Mason are studying a critical question in type 1 diabetes: Why do some people who get type 1 diabetes continue to produce small amounts of insulin over time while others stop? Researchers have found at the time of diagnosis with type 1 diabetes that many people continue to produce small amounts of insulin.
Acorda Therapeutics, Inc. today announced that it plans to relocate its corporate headquarters to the Ardsley Park life science campus in Ardsley, New York, which was acquired by BioMed Realty Trust, Inc..
Daniel Touizer, CEO of Cinergy Health, a nationwide provider of guaranteed issue health insurance benefit programs, is concerned that the labor department's recently released U-6 number means nearly one in five Americans are without a full-time job and unlikely to have health insurance.
APEIRON Biologics AG announced today that GlaxoSmithKline, exclusive, worldwide licensee for Apeiron's new investigational recombinant human Angiotensin Converting Enzyme 2 (rhACE2, name: GSK2586881, formerly APN01), has initiated a phase IIa study in patients suffering from Acute Lung Injury.
› Verified 1 days ago
| Entity Name | Dlp Conemaugh Physician Practices Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1932515905 PECOS PAC ID: 7315166949 Enrollment ID: O20140915002522 |
News Archive
Three generic drugmakers are being accused in a whistleblower lawsuit of scheming to overcharge the government by tens of millions of dollars for medicines.
Scientists at Benaroya Research Institute at Virginia Mason are studying a critical question in type 1 diabetes: Why do some people who get type 1 diabetes continue to produce small amounts of insulin over time while others stop? Researchers have found at the time of diagnosis with type 1 diabetes that many people continue to produce small amounts of insulin.
Acorda Therapeutics, Inc. today announced that it plans to relocate its corporate headquarters to the Ardsley Park life science campus in Ardsley, New York, which was acquired by BioMed Realty Trust, Inc..
Daniel Touizer, CEO of Cinergy Health, a nationwide provider of guaranteed issue health insurance benefit programs, is concerned that the labor department's recently released U-6 number means nearly one in five Americans are without a full-time job and unlikely to have health insurance.
APEIRON Biologics AG announced today that GlaxoSmithKline, exclusive, worldwide licensee for Apeiron's new investigational recombinant human Angiotensin Converting Enzyme 2 (rhACE2, name: GSK2586881, formerly APN01), has initiated a phase IIa study in patients suffering from Acute Lung Injury.
› Verified 1 days ago
| Entity Name | Dlp Conemaugh Memorial Medical Center Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1669873881 PECOS PAC ID: 8022238682 Enrollment ID: O20141015000769 |
News Archive
Three generic drugmakers are being accused in a whistleblower lawsuit of scheming to overcharge the government by tens of millions of dollars for medicines.
Scientists at Benaroya Research Institute at Virginia Mason are studying a critical question in type 1 diabetes: Why do some people who get type 1 diabetes continue to produce small amounts of insulin over time while others stop? Researchers have found at the time of diagnosis with type 1 diabetes that many people continue to produce small amounts of insulin.
Acorda Therapeutics, Inc. today announced that it plans to relocate its corporate headquarters to the Ardsley Park life science campus in Ardsley, New York, which was acquired by BioMed Realty Trust, Inc..
Daniel Touizer, CEO of Cinergy Health, a nationwide provider of guaranteed issue health insurance benefit programs, is concerned that the labor department's recently released U-6 number means nearly one in five Americans are without a full-time job and unlikely to have health insurance.
APEIRON Biologics AG announced today that GlaxoSmithKline, exclusive, worldwide licensee for Apeiron's new investigational recombinant human Angiotensin Converting Enzyme 2 (rhACE2, name: GSK2586881, formerly APN01), has initiated a phase IIa study in patients suffering from Acute Lung Injury.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Jihad Elias Azar, MD 1086 Franklin St, Johnstown, PA 15905-4305 Ph: (814) 410-8300 | Jihad Elias Azar, MD 1111 Franklin St, Ste 300, Johnstown, PA 15905-4330 Ph: (814) 534-9230 |
News Archive
Three generic drugmakers are being accused in a whistleblower lawsuit of scheming to overcharge the government by tens of millions of dollars for medicines.
Scientists at Benaroya Research Institute at Virginia Mason are studying a critical question in type 1 diabetes: Why do some people who get type 1 diabetes continue to produce small amounts of insulin over time while others stop? Researchers have found at the time of diagnosis with type 1 diabetes that many people continue to produce small amounts of insulin.
Acorda Therapeutics, Inc. today announced that it plans to relocate its corporate headquarters to the Ardsley Park life science campus in Ardsley, New York, which was acquired by BioMed Realty Trust, Inc..
Daniel Touizer, CEO of Cinergy Health, a nationwide provider of guaranteed issue health insurance benefit programs, is concerned that the labor department's recently released U-6 number means nearly one in five Americans are without a full-time job and unlikely to have health insurance.
APEIRON Biologics AG announced today that GlaxoSmithKline, exclusive, worldwide licensee for Apeiron's new investigational recombinant human Angiotensin Converting Enzyme 2 (rhACE2, name: GSK2586881, formerly APN01), has initiated a phase IIa study in patients suffering from Acute Lung Injury.
› Verified 1 days ago
Robert Mucciola, MD Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 1503 Scalp Ave, Johnstown, PA 15904 Phone: 814-262-0333 Fax: 814-262-7129 | |
Albert K Mall, MD Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 1111 Franklin St, Suite 230, Johnstown, PA 15905 Phone: 814-262-7980 Fax: 814-262-7983 | |
Delbert Lynn Yoder, MD Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 1111 Franklin St, Suite 300, Johnstown, PA 15905 Phone: 814-534-9230 Fax: 814-534-9465 | |
Anne M Sterlin, MD Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 1111 Franklin St, Suite 300, Johnstown, PA 15905 Phone: 814-534-9203 Fax: 814-534-9465 | |
Adib Najib Khouzami, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 1111 Franklin St, Ste 300, Johnstown, PA 15905 Phone: 814-534-9230 Fax: 814-534-9465 | |
Dr. Bahige Henry Arida, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 1020 Franklin St Ste 300, Johnstown, PA 15905 Phone: 814-244-0981 |